Latest News


Neuroscience

Innovative research on show.

An impressive group of emerging leaders addressed the Kolling’s Neuroscience and Pain Showcase, sharing details of their diverse and exciting research projects. With a broad range of expertise in this field, the showcase involved representatives from the pain management and rehabilitations teams, as well as the ageing, mental health, neurogenetics and neuromuscular imaging groups. The ea.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Australia to introduce ground breaking technology to target debilitating Mito disease.

Clinicians, researchers and patients have welcomed a landmark law which will pave the way for remarkable new IVF technology to prevent mitochondrial disease. Known as “Maeve’s law” after a young Victorian girl with a rare genetic disorder, the legislation was passed by Federal Parliament allowing the specialised IVF procedure to be carried out in Australia. It will involve replacing faul.....
Read more

Category: Neuroscience and Pain Research, New Treatment, World-leading technology

New cutting-edge technology coming to the Kolling.

The Kolling is set to be one of the first institutes in New South Wales to introduce new world-leading technology, boosting our cancer and neuroscience research capabilities. The Digital Spatial Profiling System has been made possible following a $535,000 grant from the Australian Research Council LIEF scheme. The project is being co-funded by the University of Sydney with a $250,000 con.....
Read more

Category: Research Excellence, World-leading technology

High-profile appointment.

The Kolling Institute’s Executive Director Professor Carolyn Sue will join a dynamic group of Australian leaders on the new National Health and Medical Research Council. Professor Sue has been appointed to the high profile body for a three-year term until June 2024. A record number of women are represented on the new council, including chair and internationally-renowned researcher Profes.....
Read more

Category: Research Excellence

Living with  Parkinson's disease.

As a single mum of four children, Jo Makamaka is juggling many responsibilities. She is not complaining though, just cherishing the opportunity to look after her children and take part in a host of activities which were not always within her reach. Jo first saw a neurologist in her early-20s in response to a collection of unusual symptoms, but it was not until many years later that she w.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

World-leading research in the spotlight.

The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling. Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people. A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disord.....
Read more

Category: Neuroscience and Pain Research, Research Excellence, World-leading technology

Researchers to improve diagnosis for genetic disorders .

Kolling researchers will drive a large, national research project to improve diagnostic rates for those with mitochondrial diseases and broaden treatment pathways. A $3 million grant from the Medical Research Future Fund is being invested in the project, which will involve clinicians, researchers and diagnostic scientists from a host of organisations including the Kolling and the Murdoch.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

High tech project offers hope for Parkinson’s treatment.

Kolling researchers are set to lead a ground-breaking project to identify new drug therapies for those with Parkinson's disease. The project has been made possible following Federal Government funding through the National Drug Discovery Centre. Senior Kolling researcher Dr Daniel Whiten has welcomed the announcement, saying the funding will help our team translate our scientific progress.....
Read more

Category: Funding support

First Australian imaging technology to deliver research windfall.

An exciting project between the University of Sydney and the Northern Sydney Local Health District will see a $15 million, revolutionary scanner installed at Royal North Shore Hospital, greatly improving patient care and research capabilities. Australia’s first Total Body Positron Emission Tomography (TB-PET) scanner will produce faster and higher quality whole-body PET/CT scans, with l.....
Read more

Category: World-leading technology

Executive Director joins elite group of Australian health professionals .

Congratulations to the Kolling’s Executive Director Professor Carolyn Sue, elected a Fellow of the Australian Academy of Health and Medical Sciences for her outstanding contribution to health and medical research in Australia. Professor Sue is part of a distinguished group recognised for their personal achievement, outstanding leadership and continuing involvement in health and medi.....
Read more

Category: Awards, Research Excellence